Every 67 Seconds: Genetics in Alzheimer’s Disease

Mayeux_2012Genes passed down from generation to generation within families are the main culprit in contracting Alzheimer’s disease. Recent research for the disease is focusing on individual variations of these genes, instead of trying to find a “one size fits all” treatment.

That was part of the message delivered by Richard Mayeux, the Gertrude H. Sergieysky co-director of the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at Columbia University Medical Center. Mayeux’s talk on the role that genetics plays in Alzheimer’s disease last Thursday evening at the 92nd Street Y in Manhattan came at an opportune time. November is both National Alzheimer’s Disease Awareness month and National Epilepsy Awareness Month.

Mayeux, M.D., MS.c., who is also Professor of Neurology, Psychiatry, and Epidemiology and a member of the Dana Alliance for Brain Initiatives, has been featured in the New York Academy of Sciences podcast series, Dementia Decoded. His research on genomes aims to understand the differences in gene structure and what it could mean for future treatment.

Continue reading

Dana News E-Blast: July

Below is yesterday’s Dana News email blast. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.

The Power of Tau

july eblastby Patrick F. Sullivan, MD, FRANZCP

In July 2014, an international consortium of schizophrenia researchers mounted the largest biological experiment in the history of psychiatry. Now, with many more avenues for exploring the biological underpinnings of schizophrenia available to neuroscientists, hope may be on the way for the estimated 1 in 100 people worldwide affected by the illness. From Cerebrum, our online magazine of ideas. Also check out a Q&A with Dr. Sullivan.

Continue reading

Dana News E-Blast: May

Below is last week’s Dana news email blast. You can sign up to receive this (and other Dana email alerts and/or print publications) by going here.

The Power of Tau

CerebrumAprilImage

by Kenneth S. Kosik, MD

Tau protein helps nerve cells in the brain maintain their function and structure. When tau turns toxic, replicates, and spreads, neurons misfire and die. If neuroscientists can pinpoint the reasons for toxicity, identify possible modified tau states, and find a way to block tau’s movement from cell to cell, then progress can be made in fighting any number of neurological disorders. From Cerebrum, our online magazine of ideas. Continue reading

Series Finale: Dementia Decoded

dementiadecoded

Continue reading

New Podcast: Dementia Decoded

dementiadecoded

Starting last week (April 23), the New York Academy of Sciences began airing weekly episodes of the new podcast series, Dementia Decoded. Sponsored by the Dana Foundation, the five-part program aims to educate the public on topics such as the history of Alzheimer’s disease, prevention, risk reduction, diagnosis, and care. The episodes also feature different specialists in the field, including our very own Dana Alliance members: Richard Mayeux, M.D., Reisa Sperling, M.D., and Rudolph Tanzi, Ph.D. (Tanzi was just acknowledged by TIME Magazine as one of the world’s top influential figures of the year for his work on finding a cure for Alzheimer’s.)

Continue reading

%d bloggers like this: